Identification of the novel HLA-A*02:974 allele by next-generation sequencing.

Humans Alleles High-Throughput Nucleotide Sequencing Histocompatibility Testing Exons / genetics HLA-A Antigens / genetics
HLA-A*02:974 HLA-A NGS new HLA allele

Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
07 2023
Historique:
received: 13 03 2023
accepted: 14 03 2023
medline: 15 6 2023
pubmed: 29 3 2023
entrez: 28 3 2023
Statut: ppublish

Résumé

The novel HLA-A*02:974 allele was characterized using next-generation sequencing technology.

Identifiants

DOI: 10.1111/tan.15039 PMID: 36975380
pubmed: 36975380
doi: 10.1111/tan.15039
doi:

Substances chimiques

HLA-A Antigens 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

68-69

Informations de copyright

© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Barker DJ, Maccari G, Georgiou X, et al. IPD-IMGT/HLA Database. Nucleic Acids Res. 2023;51:D1053-D1060.
Marsh SGE, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system. Tissue Antigens. 2010;75:291-455.

Auteurs

Anastasiia Ananeva (A)

Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation.
ORCID: 0000-0002-8069-7244

Gulnaz Akhmetshina (G)

Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation.

Anna Andryushkina (A)

National Bone Marrow Donors Registry Named After Vasya Perevoshchikov, Moscow, Russian Federation.

Elena Shagimardanova (E)

Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation.
ORCID: 0000-0003-2339-261X

Articles similaires

Comprehensive comparative analysis and development of molecular markers for Lasianthus species based on complete chloroplast genome sequences.

Yue Zhang, Meifang Song, Deying Tang et al.
1.00
Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Identification of the novel HLA-A*02:974...
questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Génome › Composants de génome › Gènes › Allèles › Identification of the novel HLA-A*02:974...
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Analyse de séquence › Séquençage nucléotidique à haut débit › Identification of the novel HLA-A*02:974...
questionsmedicales.fr › Techniques d'investigation › Techniques immunologiques › Tests immunologiques › Test d'histocompatibilité › Identification of the novel HLA-A*02:974...
questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Génome › Composants de génome › Gènes › Composants de gène › Exons › Identification of the novel HLA-A*02:974...
questionsmedicales.fr › Facteurs biologiques › Antigènes › Isoantigènes › Antigènes d'histocompatibilité › Antigènes HLA › Antigènes HLA-A › Identification of the novel HLA-A*02:974...